These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31630256)

  • 1. How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study.
    Mori M; Morita T; Matsuda Y; Yamada H; Kaneishi K; Matsumoto Y; Matsuo N; Odagiri T; Aruga E; Watanabe H; Tatara R; Sakurai H; Kimura A; Katayama H; Suga A; Nishi T; Shirado AN; Watanabe T; Kuchiba A; Yamaguchi T; Iwase S
    Support Care Cancer; 2020 Jul; 28(7):3051-3060. PubMed ID: 31630256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Successful Is Parenteral Oxycodone for Relieving Terminal Cancer Dyspnea Compared With Morphine? A Multicenter Prospective Observational Study.
    Mori M; Kawaguchi T; Imai K; Yokomichi N; Yamaguchi T; Suzuki K; Matsunuma R; Watanabe H; Maeda I; Uehara Y; Morita T;
    J Pain Symptom Manage; 2021 Aug; 62(2):336-345. PubMed ID: 33290857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study.
    Mori M; Kawaguchi T; Imai K; Yokomichi N; Yamaguchi T; Suzuki K; Matsunuma R; Watanabe H; Maeda I; Matsumoto Y; Matsuda Y; Morita T;
    J Pain Symptom Manage; 2021 Nov; 62(5):936-948. PubMed ID: 33992759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
    Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
    J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study.
    Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
    J Palliat Med; 2017 Apr; 20(4):352-359. PubMed ID: 28379811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
    Maeda T; Hayakawa T
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
    Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
    J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
    Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
    Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
    Hu WY; Chiu TY; Cheng SY; Chen CY
    J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study.
    Mori M; Yamaguchi T; Suzuki K; Matsuda Y; Matsunuma R; Watanabe H; Ikari T; Matsumoto Y; Imai K; Yokomichi N; Miwa S; Yamauchi T; Okamoto S; Inoue S; Inoue A; Hui D; Morita T; Satomi E;
    J Pain Symptom Manage; 2023 Aug; 66(2):e177-e184. PubMed ID: 37080479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.
    Morita T; Chinone Y; Ikenaga M; Miyoshi M; Nakaho T; Nishitateno K; Sakonji M; Shima Y; Suenaga K; Takigawa C; Kohara H; Tani K; Kawamura Y; Matsubara T; Watanabe A; Yagi Y; Sasaki T; Higuchi A; Kimura H; Abo H; Ozawa T; Kizawa Y; Uchitomi Y;
    J Pain Symptom Manage; 2005 Oct; 30(4):320-8. PubMed ID: 16256896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    Kawaguchi J; Hamatani Y; Hirayama A; Nishimura K; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Kuroda K; Azechi M; Takahama H; Anzai T; Yasuda S; Kitaoka H; Izumi C
    J Cardiol; 2020 Jun; 75(6):682-688. PubMed ID: 32061472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study.
    Mori M; Shirado AN; Morita T; Okamoto K; Matsuda Y; Matsumoto Y; Yamada H; Sakurai H; Aruga E; Kaneishi K; Watanabe H; Yamaguchi T; Odagiri T; Hiramoto S; Kohara H; Matsuo N; Katayama H; Nishi T; Matsui T; Iwase S
    Support Care Cancer; 2017 Apr; 25(4):1169-1181. PubMed ID: 27900548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients.
    Takeyasu M; Miyamoto A; Kato D; Takahashi Y; Ogawa K; Murase K; Mochizuki S; Hanada S; Uruga H; Takaya H; Morokawa N; Kishi K
    Intern Med; 2016; 55(7):725-9. PubMed ID: 27041155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized morphine in the palliation of dyspnoea.
    Zeppetella G
    Palliat Med; 1997 Jul; 11(4):267-75. PubMed ID: 9373577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Oral Morphine on Dyspnea in Patients with Cancer: Response Rate, Predictive Factors, and Clinically Meaningful Change (CJLSG1101).
    Takahashi K; Kondo M; Ando M; Shiraki A; Nakashima H; Wakayama H; Kataoka K; Yamamoto M; Sugino Y; Nishikawa M; Imaizumi K; Kojima E; Sumida A; Takeyama Y; Saito H; Hasegawa Y
    Oncologist; 2019 Jul; 24(7):e583-e589. PubMed ID: 30659079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer.
    Lawlor PG; Nekolaichuk C; Gagnon B; Mancini IL; Pereira JL; Bruera ED
    Cancer; 2000 Jun; 88(12):2859-67. PubMed ID: 10870073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study.
    Yamaguchi T; Matsunuma R; Matsuda Y; Tasaki J; Ikari T; Miwa S; Aiki S; Takagi Y; Kiuchi D; Suzuki K; Oyamada S; Ariyoshi K; Kihara K; Mori M
    J Pain Symptom Manage; 2023 May; 65(5):400-408. PubMed ID: 36641006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study.
    Taniguchi Y; Matsuda Y; Mori M; Ito M; Ikari T; Tokoro A; Aiki S; Hoshino S; Kiuchi D; Suzuki K; Igarashi Y; Odagiri T; Oya K; Kubo E; Yamaguchi T
    Transl Lung Cancer Res; 2022 Dec; 11(12):2395-2402. PubMed ID: 36636410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer.
    Boyd KJ; Kelly M
    Palliat Med; 1997 Jul; 11(4):277-81. PubMed ID: 9373578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.